ATRC - AtriCure, Inc.

30.02
-0.290   -0.966%

Share volume: 454,864
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$30.31
-0.29
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 35%
Dept financing 29%
Liquidity 59%
Performance 32%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.94%
1 Month
-18.69%
3 Months
-22.91%
6 Months
-16.61%
1 Year
-13.04%
2 Year
-19.24%
Key data
Stock price
$30.02
P/E Ratio 
0.00
DAY RANGE
$29.07 - $30.38
EPS 
-$0.24
52 WEEK RANGE
$28.29 - $43.18
52 WEEK CHANGE
-$10.49
MARKET CAP 
1.967 B
YIELD 
N/A
SHARES OUTSTANDING 
49.810 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-29-2025
BETA 
1.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$528,927
AVERAGE 30 VOLUME 
$858,392
Company detail
CEO: Michael H. Carrel
Region: US
Website: atricure.com
Employees: 1,050
IPO year: 2005
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue and systems, and intercostal nerves. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products. CryoICE Cryoablation System enables the user to make linear ablations of varied lengths. EPi-Sense Guided Coagulation System is used to treat persistent atrial fibrillation.

Recent news